抄録
We reviewed the medical charts and conducted a questionnaire survey of 298 outpatients to examine the use of antidiabetic drugs and side effects.
Of the first prescribed medicines, the ratio of Rastinon® (tolbutamide) was the highest and about 90%were sulfonylureas. At present, 52% of the prescribed medicines are sulfonylureas, 21 % are sulfonylureas and either an α-glucosidase inhibitor or a reducer of insulin resisitance, while 11% receive insulin.
The side effects of these antidiabetic drugs include hypoglycemia by sulfonylureas or insulin, digestive symptoms due to α-glucosidase inhibitor, among others.
